CSF1R and lung carcinoma: In a Kaplan–Meier analysis, high expression levels of CSF1R were associated with higher lung cancer-specific mortality (5 years survival: 61 months) than low–moderate expression levels of CSF1R (5 years survival: 73 months; log-rank p = 0.037) (Figure 2A).